Breaking News

Lonza Completes Expansion to Solid Form Services Facility at Oregon Site

The offering complements Lonza’s API development services and first-in-human services, aimed at the rapid advancement of small molecules.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lonza has completed a planned expansion to its Solid Form Services (SFS) offering for small molecule drugs. The expanded facility in Bend, OR (US) became fully operational in Q4 2022, enhancing Lonza’s capabilities in meeting accelerated timelines for increasingly complex molecules. The expanded facility includes remodeled and dedicated laboratory space which is primarily being used to support biotech and midsize pharma companies in developing early-stage compounds. It can support all a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters